CME Group Financial Statements
NASDAQ: CMEFinanceInvestment Bankers/Brokers/ServiceUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CME Group revenue and earnings
In fiscal 2025, CME Group generated $6.52 billion in revenue, up 6.4% from fiscal 2024, its 4th consecutive year of revenue growth. Net income was $4.07 billion (+15.5% year over year), for a net margin of 62.5% versus a median of 56.2% in the prior 5 years. Operating margin was 64.9%.
Diluted earnings per share came in at $11.16, up from $9.67. Over the last 5 fiscal years, CME's revenue has grown at a 6.0% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
CME Group income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.52B | 6.13B | 5.58B | 5.02B | 4.69B | 4.88B | 4.87B | 4.31B | 3.64B | 3.60B |
| Revenue growth (YoY) | +6.37% | +9.88% | +11.15% | +7.03% | -3.97% | +0.32% | +12.96% | +18.24% | +1.38% | +8.07% |
| Operating Income | 4.23B | 3.93B | 3.44B | 3.02B | 2.65B | 2.64B | 2.59B | 2.61B | 2.31B | 2.20B |
| Interest Expense | 173.40M | 160.90M | 159.40M | 162.70M | 166.90M | 166.20M | 178.00M | 157.70M | 117.00M | 123.50M |
| Other Income (Expense) | 1.10B | 609.90M | 717.90M | 474.40M | 728.40M | 84.70M | 101.80M | 170.20M | 215.70M | 87.10M |
| Pretax Income | 5.33B | 4.54B | 4.15B | 3.49B | 3.37B | 2.72B | 2.69B | 2.78B | 2.53B | 2.29B |
| Income Tax | 1.26B | 1.02B | 927.40M | 799.30M | 736.70M | 615.70M | 573.80M | 814.10M | -1.54B | 753.50M |
| Net Income | 4.07B | 3.53B | 3.23B | 2.69B | 2.64B | 2.11B | 2.12B | 1.96B | 4.06B | 1.53B |
| Net Income growth (YoY) | +15.50% | +9.29% | +19.88% | +2.05% | +25.21% | -0.50% | +7.86% | -51.71% | +164.87% | +23.02% |
| EPS (Basic) | 11.18 | 9.69 | 8.87 | 7.41 | 7.30 | 5.88 | 5.93 | 5.73 | 12.00 | 4.55 |
| EPS (Diluted) | 11.16 | 9.67 | 8.86 | 7.40 | 7.29 | 5.87 | 5.91 | 5.71 | 11.94 | 4.53 |
| Shares Outstanding (Basic) | 359.65M | 359.39M | 359.02M | 358.71M | 358.34M | 357.76M | 357.15M | 342.34M | 338.71M | 337.50M |
| Shares Outstanding (Diluted) | 360.31M | 359.94M | 359.50M | 359.18M | 358.93M | 358.52M | 358.24M | 343.74M | 340.23M | 338.97M |
| EBITDA | 4.34B | 4.05B | 3.56B | 3.15B | 2.79B | 2.79B | 2.75B | 2.73B | 2.42B | 2.33B |
| Operating Margin | 64.86% | 64.13% | 61.58% | 60.08% | 56.40% | 54.01% | 53.16% | 60.51% | 63.40% | 61.21% |
| Net Margin | 62.45% | 57.52% | 57.83% | 53.61% | 56.23% | 43.12% | 43.48% | 45.53% | 111.49% | 42.67% |
This table shows 10 annual periods of CME Group's income statement, from FY 2025 back to FY 2016, across 14 line items including revenue, operating income, interest expense. Values in USD; B = billions, M = millions. Fiscal periods follow CME's reporting calendar. What is a income statement?